Verifix-25 Tablet

We are engaged in manufacturing and supplying of Verifix-25 Tablet in New Delhi, Delhi, India. Cinnarizine inhibits contractions of vascular smooth muscle cells by blocking calcium channels. Cinnarizine increases erythrocyte deformability and decreases blood viscosity in vitro. Cinnarizine inhibits stimulation of the vestibular system. Indications: Verifix-25 controlsthe vestibular symptoms of both peripheral and central origin and of labyrinthine disorders including vertigo, dizziness, tinnitus, nystagmus, nausea and vomiting. Prophylaxis of motion sickness.Adjunct therapy for symptoms of peripheral arterial disease.

Dosage and Directions for Use:As with other antihistamines, Verifix-25 tablets may causeepigastric distress; taking it after meals may diminish gastric irritation.

Adults and children over the age of 12 years:
Peripheral-circulatory-disorders:2-3 x 25 mg tablets three times daily.
Disorders ofbalance: 1 x 25 mg tablet three times daily.
Motion-sickness:
Adults: 25 mg may be taken 2 hours before the start of the journey and 12,5 mg to 25 mg may be repeated every 8 hours during the journey when necessary.
Children 8 to 12 years: 12,5 mg (half a tablet) three times daily when necessary.
Children 5 to 7 years:6,25 mg three times daily when necessary.